Product image of Kitolak (Ciclopirox) supplied by GNH India

Kitolak

Active Ingredient:
Ciclopirox
Origin:
EU

Kitolak (Ciclopirox)

Ciclopirox, the active ingredient in Kitolak, is an antifungal presented as a topical formulation for skin application. It is used to treat fungal infections of the skin and nails in adults and children when appropriate.
GNH India supplies Kitolak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medico Uno Pharmaceuticals Se

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ciclopirox is an antifungal that targets dermatophyte and yeast infections of the skin.

  • Tinea pedis: reduces itching, scaling and erythema caused by athlete's foot.
  • Tinea corporis: clears ring‑shaped lesions and prevents spread of the infection.
  • Candidiasis: treats cutaneous candidal eruptions, relieving redness and discomfort.
  • Dermatophytosis: eliminates fungal colonies on the skin, promoting healing and preventing recurrence.

How It Works

  • Ciclopirox chelates polyvalent cations such as Fe3+ and Al3+, inhibiting metal‑dependent enzymes essential for fungal metabolism. This disruption impairs cell membrane function and interferes with the synthesis of essential sterols, leading to loss of cellular integrity and fungal cell death.

Side Effects

Ciclopirox may cause local skin reactions.

Common Side Effects

  • Itching: mild to moderate sensation at the application site.
  • Burning: transient heat sensation after application.
  • Redness: localized erythema.
  • Dryness: skin may feel less moist.
  • Irritation: mild discomfort or stinging.
  • Scaling: flaking of the treated area.

Serious or Rare Side Effects

  • Allergic reaction: hives, swelling, or difficulty breathing.
  • Severe dermatitis: extensive redness, blistering, or oozing.
  • Swelling: localized edema at the site.
  • Blistering: formation of fluid‑filled lesions.
  • Contact urticaria: rapid wheal formation after contact.
  • Systemic toxicity: rare liver enzyme abnormalities with extensive use.

Precautions & Warnings

Ciclopirox should be used with care to minimise adverse reactions.

  • Avoid application on broken or inflamed skin: may increase irritation.
  • Discontinue if severe redness or swelling occurs: seek medical advice.
  • Keep away from eyes and mucous membranes: avoid accidental contact.
  • Do not use on children under 2 years unless directed: safety not established.
  • Do not cover with occlusive dressings unless instructed: may enhance absorption.
  • Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Ciclopirox can interact with other topical agents and systemic medications.

Major Interactions (Avoid)

  • Concurrent use with other topical antifungals: may increase local irritation.
  • Combination with potent corticosteroids: may reduce antifungal efficacy.
  • Application with photosensitizing agents: heightened risk of phototoxic reactions.

Moderate Interactions (Monitor Closely)

  • Use alongside systemic antifungals: monitor for additive systemic exposure.
  • Co‑application with skin irritants (e.g., harsh soaps): may exacerbate dermatitis.
  • Use with alcohol‑based cleansers: can increase drying and irritation.

Frequently Asked Questions

Kitolak contains ciclopirox, a topical antifungal indicated for the treatment of skin fungal infections such as athlete's foot (tinea pedis), ringworm (tinea corporis), cutaneous candidiasis, and other dermatophytoses. It helps relieve symptoms like itching, scaling, and redness while eliminating the underlying fungus.

Ciclopirox works by chelating essential metal ions such as iron and aluminum, which are required for fungal enzyme activity. This inhibition disrupts metal‑dependent metabolic pathways, compromises the fungal cell membrane, and ultimately leads to cell death, reducing the infection.

The dosage of Kitolak is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin involved. The prescriber will provide specific instructions on how much to apply and how often.

Safety data for ciclopirox in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing Kitolak to pregnant or nursing women. Consultation with a physician is essential.

To order Kitolak, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with azole or allylamine topical agents, ciclopirox has a distinct mechanism that does not rely on inhibiting ergosterol synthesis. This can be advantageous in cases of resistance to azoles. Its safety profile is generally favorable, though local irritation may be more common.

Kitolak should be stored at room temperature below 25 °C, in its original packaging to protect it from moisture and light. Keeping the container tightly closed helps maintain product stability and potency.

Kitolak is applied topically to the affected skin area. The prescribed amount is spread thinly and gently rubbed in, usually once or twice daily, as directed by the healthcare professional. Hands should be washed before and after application.

Serious risks, though rare, include severe allergic reactions such as hives, swelling of the face or throat, and extensive dermatitis with blistering. If any of these occur, the product should be discontinued immediately and medical attention sought.

Kitolak should not be used on patients with known hypersensitivity to ciclopirox or any of the formulation components. It is also contraindicated on heavily broken, ulcerated, or inflamed skin unless specifically advised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ciclopirox

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT